Sanford Laboratories For Innovative Medicines
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2022 | 2,001,082 | 15,825 | 1,985,257 | 1505.4 | 0% |
| 2023 | 12,532,763 | 3,933,217 | 8,599,546 | 32.3 | 31% |
In its most recent public year (2023), this organization brought in $8,599,546 more than it spent. Its reserves stood at about 32.3 months of spending, down from 1505.4 in 2022. Staff pay was 31% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works